Surgery Partners' stock surged 7.15% in after-hours trading on Tuesday, following the release of its first-quarter 2026 financial results.
The company reported adjusted earnings per share of -$0.03, significantly beating the analyst consensus estimate of -$0.12. Revenue for the quarter rose 4.5% year-over-year to $810.9 million, surpassing expectations of $797.89 million. Adjusted EBITDA of $102.3 million also exceeded forecasts.
Furthermore, Surgery Partners reaffirmed its full-year 2026 guidance, expecting revenue between $3.35 billion and $3.45 billion and adjusted EBITDA of at least $530 million. This positive earnings surprise and maintained outlook likely fueled investor optimism, driving the stock price higher in extended trading.
Comments